Skip to main content
Clinical Trials/NCT00999193
NCT00999193
Terminated
Not Applicable

Effectiveness and Cost-effectiveness of Conservative and Operative Treatment of Three- and Four-part Fractures of the Proximal Humerus. A Nested Randomised Controlled Trial and Cohort Study

University of Helsinki1 site in 1 country60 target enrollmentNovember 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Humeral Fracture
Sponsor
University of Helsinki
Enrollment
60
Locations
1
Primary Endpoint
Constant Score
Status
Terminated
Last Updated
last year

Overview

Brief Summary

Fractures of the proximal humerus are common in elderly patients. The optimal treatment of comminuted, displaced fractures is subject to controversy, and the results of operative treatment have not been shown to be superior to conservative treatment. The aim of the study is to compare locking plate osteosynthesis versus treatment with fracture hemiarthroplasty versus conservative treatment in a randomised, controlled protocol. The results of treatment are measured at 6 weeks, 3 months, 6 months, 12 months and 24 months. Main outcome measures are Pain at rest and activity (NRSs) and functional assessment of the shoulder with Constant Score. Secondary outcome measures are Simple Shoulder test (SST), Disabilities of the Arm, Shoulder and Hand (DASH), quality of life assessment (15D), subjective patient satisfaction and costs. The study also has a cohort follow-up of the patiens who decline randomisation.

The recruitment target was 90 patients, but the study recruitment was stopped due to slow recruitment (too few patients presenting with eligibile injury to the hospital) at 60 patients in November 2019.

Registry
clinicaltrials.gov
Start Date
November 2010
End Date
February 22, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Tuomas Lahdeoja

MD

University of Helsinki

Eligibility Criteria

Inclusion Criteria

  • Age 65 years and older
  • Acute trauma:
  • randomisation (op vs cons) within 7 days of injury.
  • 3- or 4-part fracture with \>5mm dislocation of the anatomic neck.
  • AO classification C1-2 for non-luxation fractures
  • AO classification C3 for luxation fractures

Exclusion Criteria

  • Head Splitting fracture
  • Open fracture
  • Additional fractures in the shoulder region
  • Other injuries requiring surgical treatment
  • Clinically significant injury of the brachial plexus or vasculature
  • Pathological fracture associated with cancer
  • History of a fracture of the clavicle, scapula or humerus, or history of a very significant disease or trauma of the shoulder region (hemiparesis, tumour, osteomyelitis, grave arthrosis etc)
  • Rheumatoid Arthritis in the shoulder requiring active treatment
  • Reduced co-operation or incapability for independent living (dementia, mental illness, drug- or alcohol abuse etc)
  • unwillingness to accept some of the treatment options.

Outcomes

Primary Outcomes

Constant Score

Time Frame: 3 mo, 6 mo, 1 year, 2 years

Pain at rest Numeric Rating Scale 0-10 (NRS)

Time Frame: 6 weeks, 3 mo, 6 mo, 1 year, 2 years

Pain in active motion NRS

Time Frame: 6 weeks, 3 mo, 6 mo, 1 year, 2 years

Secondary Outcomes

  • Subjective satisfaction(6 weeks, 3 mo, 6 mo, 1 year, 2 years)
  • Simple Shoulder Test (SST)(3 mo, 6 mo, 1 year, 2 years)
  • Quality of life assessed with 15D(6 weeks, 3 mo, 6 mo, 1 year, 2 years)
  • Disabilities of the Arm, Shoulder and Hand (DASH)(3 mo, 6 mo, 1 year, 2 years)
  • Complications(6 weeks, 3 mo, 6 mo, 1 year, 2 years)

Study Sites (1)

Loading locations...

Similar Trials